Cell therapy with IL-10-producing group 2 innate lymphoid cells suppresses Graft-versus-Host disease
K. T. Reid, S. J. Colpitts, J. A. Mathews, A. S. Carreira, J. M. Murphy, D. T. Borovsky, W. Cui, T. A. Moya, N. Sachewsky, J. An, Y. Xia, A. Mortha, J. B. Lee, L. Zhang, I. Novitzky-Basso, , S. Q. Crome
This study demonstrates that IL-10-producing group 2 innate lymphoid cells (ILC210) can suppress Graft-versus-Host Disease (GVHD) in a humanized model without compromising graft-versus-leukemic effects.
bioRxiv · Aug 21, 2023Immunology